About

The Health Sciences Entrepreneurs program (HSE) operates within the Bouvé College of Health Sciences, and was created to introduce entrepreneurial business opportunities in the health and life sciences to Northeastern University innovators. The program was founded in 2005 by alumnus Joseph Fleming, PAH ’70, MS ’71, and focuses on educating alumni, student, staff and faculty entrepreneurs by providing them with the knowledge and tools to build successful companies.

At the Bouvé College of Health Sciences, we have many disciplines that lend themselves to the entrepreneurial world; pharmacy, nursing, drug development, physical therapy, public health, health informatics, digital health, telemedicine, audiology and speech language, physician assistant, counseling and pre-med.  Though many of our entrepreneurs come from the Bouvé College of Health Sciences, HSE supports innovators from across all disciplines.

HSE hosts annual events in entrepreneurship and in 2010 launched a mentoring program for alumni, students, staff and faculty from Northeastern who are starting businesses in healthcare, health sciences and life sciences. Ventures apply to the program and, if selected, have access to a mentoring team that meets regularly with the venture to help develop the venture to a launch state.

In addition, the program supports various formal educational opportunities such as the new Entrepreneurship in Health Sciences course. This class is now offered each spring is the cornerstone for the NEW Health Sciences Entrepreneurship Minor!

Health Sciences Entrepreneurs
Above all else, the Bouve HSE program gave me the confidence that I need to enter the healthcare market. As a pharmacy student or professional, it is extremely daunting and almost frightening to even think about launching your own company because you do not know where to begin…This program offered me an opportunity to listen and learn from successful entrepreneurs in various aspects of the industry. This provided me with not only new knowledge, but also motivation to work hard and become a successful entrepreneur or a future healthcare business leader.
– Paresh Kumar, PharmD Student ’14

Health Sciences Entrepreneurs Team

Gene Tunik

Gene Tunik PhD PT

BS ’97, Associate Dean of Research and Innovation, Bouvé College of Health Sciences

Bio

Dr. Tunik received his B.S. in Physical Therapy from Northeastern University, PhD in Neuroscience from Rutgers University, and completed a postdoctoral fellowship at Department of Psychological and Brain Science at Dartmouth College. Prior to coming to Northeastern in 2015, Dr. Tunik has held faculty appointments at NYU and Rutgers University. His primary research interest is in the study of brain mechanisms involved in human motor control, motor learning, and motor recovery from disease.

Tara Hayek

BS Mechanical Engineering, 2023, Communications Specialist and Operations Assistant (Work Study)

Dor Perl

BS Psychology 2023, Communications Specialist and Operations Assistant (Work Study)

Parshva Shah

BS Accounting and Finance 2023, Communications Specialist and Operations Assistant (Work Study)

Zainab Adenaike

BS Marketing Analytics, 2023, Communications Specialist and Operations Assistant (Work Study)
Health Sciences Entrepreneurs Board Members

Joseph Fleming

P ’70, MS ’71
Distinguished Chair Emeritus

Chairman, Infusion Ventures, Inc.

Bio

Joseph Fleming has dedicated his career to excellence in the fields of pharmacy and healthcare services. He holds a B.S. in Pharmacy and an M.S. in Pharmacology from Northeastern University. In 2005, he founded the Health Science Entrepreneurs (HSE) at Northeastern. HSE is a volunteer organization of alumni and friends who have founded health science companies and who desire to give back to the university. Several times a year, alumni in the healthcare industry return to campus for discussion of healthcare issues and to mentor entrepreneurial students and alumni. He is chairman of HSE and currently involved in an active mentoring program for young health science companies. The program is funded through direct contributions from alumni and friends.

Mr. Fleming is the Chairman of Infusion Ventures, Inc. a vascular access and infusion nursing company servicing the New England states. Mr. Fleming cofounded the company in 2010 to participate in the growing filed of vascular access. The company employs vascular access nurses who specialize in infusion therapy management in all settings including acute care hospitals, long term care facilities, physicians offices and patients’ homes. Professional staff consists of CRNI, PICC and peripheral IV certified nurses who provide specialized treatment to pediatric, adolescent, adult and geriatric patients.

In 2007 and 2008, Mr. Fleming was Executive in Residence with Beecken, Petty, Okeefe and Company (BPOC), a healthcare focused private equity firm. At BPOC, he sourced and reviewed several opportunities in the home infusion, specialty pharmacy and specialty distribution markets. Since 2008, he is an Operating Partner with a private equity firm, Seguin Partners. At Seguin, Mr. Fleming evaluates all healthcare related opportunities.

In September of 2003, Mr. Fleming co-founded Specialty Pharma, Inc. (SPI) and led a management buy-out of Professional Home Care Services, Inc. with Eureka Growth Capital. SPI is a comprehensive specialty infusion and pharmacy company that provides high quality service and intravenous drugs to patients in a variety of alternate site settings combined with low-cost, high-growth mail order distribution of self-injectable drugs. SPI grew to service over 2,500 patients per month in southern New England. As chairman, Mr. Fleming negotiated and executed several distribution and disease management agreements with biotech manufacturers. He had direct involvement with the company’s sales force which doubled in size in two years. The company was successfully sold in 2006 to Kohlberg and Company, providing healthy returns to the shareholders.

Mr. Fleming was also co-founder, president and chief executive officer of Community Rehab Centers, one of the largest networks of rehabilitation centers in the Northeast, which he successfully sold in 2001. Other past professional roles include Vice President Universal Management Systems, a home healthcare group purchasing organization and consulting company, and vice president and general manager of Home Health at ITS, Inc., a subsidiary of American Medical International, Inc. During the 1970s, he was a community pharmacist and durable medical equipment dealer in the greater Boston area.

As notable as his impact in the field of pharmacy, Mr. Fleming is also a committed volunteer on several fronts in the community. His volunteer activities include serving as past board member and volunteer for Hospice West, Inc., and he is past president and former fundraising chair of the Nashoba Regional Scholarship Foundation, which is part of Dollars for Scholars, a national organization of more than 1,200 community-based scholarship foundations.

Mr. Fleming and his wife, Nancy, also a pharmacy graduate, live in Stow, Mass. Their children have launched careers of their own: Katie , an Educational Consultant resides in New York city and Christopher as a standup comic and actor residing in Los Angeles.

Christopher Ford

DMSB ’73, Co-Chair

Chairman (Ret.) & Co-Founder, American Renal Associates, Inc.

Bio

American Renal Associates, Inc. (ARA) is one of the largest dialysis providers in the US and offers physicians an alternative to traditional large dialysis chain ownership.

Chris co-founded ARA in August 1999 with two colleagues from Fresenius Medical Care (FMC), the world’s largest dialysis company.

As of June 30, 2018, ARA owns and operates over 228 outpatient dialysis clinics, in 26 states and the District of Columbia, treating approximately 15,700 patients and employing over 3,800.

Formerly Chris was the President of FMC’s International Services Division. He grew the Fresenius international division from a small presence in Spain and Portugal, to a worldwide organization providing care for 10,000 chronic dialysis patients in 14 countries.

He has worked in the dialysis services industry since 1971, and during his 40+ year career he has contributed to the build out of the U.S. dialysis market from its infancy in the 1970’s to an $8 billion healthcare business today.

Chris received his BS degree in Business Administration from Northeastern University.

Arnold Friedman

Co-Chair

Senior Counsel, Synesis Law P.C.

Bio

Arnold Friedman is a seasoned mentor and member of the Advisory Group for Health Sciences Entrepreneurs at Northeastern University’s Bouvé College of Health Sciences. He has over thirty years of legal experience, including service as Vice President and Deputy General Counsel of Textron Inc., a $13B multi-industry company. He is currently Senior Counsel at Synesis Law. His private practice experience includes Massachusetts and Rhode Island. Arnold serves on the Rhode Island Visiting Nurses Association Foundation Board of Trustees and the Advisory Board for Nurse Innovation and Entrepreneurship at Northeastern.

Kathleen Hagan

Founder and President, Hagan & Co.

Bio

Kathleen Hagan is President of Hagan & Company, an international marketing and management consulting firm. Her current areas of industry focus include: healthcare technology, medical devices, life sciences, software, cyber-security, analytical instruments and robotics. She has thirty five years of leadership experience in international marketing and business development, entrepreneurship and technology commercialization, government and higher education. Ms. Hagan sits on several corporate, professional, and non-profit boards including Core Systems an Irish software company. She is an entrepreneur and passionate about helping entrepreneurs succeed.

Kathleen has held a number of leadership positions in entrepreneurial business management including: Founding Director of the Northern Ireland Technology and Development Center, a venture center for innovative high growth technology companies from Northern Ireland; Director of International Programs at Babson College which has been ranked #1 in entrepreneurship education in the U.S. for the past 15 years by U.S. News and World Report; and Executive Director of the MIT Enterprise Forum, an entrepreneurship education program of the Massachusetts Institute of Technology delivered in 25 cities in the U.S. and around the world.

She has a broad background in international business and government affairs. She was Director of Foreign Trade for the Massachusetts Port Authority responsible for the Authority’s overseas offices in London and Tokyo and programs to develop international business for New England companies in Europe, Asia, Latin America, and Africa. She was also District Office Director for former U.S. Senator Edward W. Brooke in charge of the Senate Massachusetts office handling a full range of policy issues including economic development and federal regulation of business.

Kathleen holds an MBA cum laude from Boston University and a BA from Trinity College, Washington, D.C. where she received the McArdle Leadership Award. She has taught Global Marketing Strategy at Babson College and at Northeastern University. She is an author and speaker on international topics and has testified before Congress on small business and international trade issues. She is a robotics industry analyst and authored the first comprehensive industry report on the Massachusetts robotics sector.

Eugene Khazan

E ’01, Product Manager of Growth Strategies, Fresenius Kidney Care and Co-Founder, CleriCare

Bio

As a graduate of the HSE mentoring program, Eugene is honored to bring his unique prospective to the board. Eugene was selected for the HSE mentoring program back in 2010 to develop a business around an idea to solve his grandparents’ problem of remembering to take their medication on time. With the help of HSE that idea evolved into CleriCare, an electronic care management company focused on serving Assisted Living Communities. Subsequently, CleriCare attracted interest and funding from the Long Term care industry and has been re-branded as BraveLeaf. Prior to starting CleriCare Eugene worked on product development at Bose Corporation, and developed a portable molecular analyzer for point-of-care infectious disease testing at IQuum. Eugene has a BS in Electrical Engineering from Northeastern University.

Danny Kim

Head of Corporate Development, Welt Corp. Pharmacist by training, Designer at heart, Investor in action.

Bio

Danny is a PharmD student at Northeastern University, where he founded ViTAL, Northeastern’s healthcare innovation hub. He also currently serves as Head of Corporated Development for Welt Corp.  Danny invests in startups with Contrary Capital, a university-focused venture firm backed by founding members of Facebook, Tesla, Reddit, Airbnb, and more. In the past, Danny recently worked at Pear Therapeutics and prior to that with PillPack, a full-service pharmacy startup simplifying medication management; the company was acquired by Amazon for $1B during his stay. He’s an advisor to several early-stage startups and family offices pertaining to their healthcare tech investments and regularly writes on The Digital Apothecary and kimdanny.com. Danny’s a Forbes 30 Under 30 Fellow, Underscore VC’s Top Rising Star in Tech, a mentor at MIT Hacking Medicine, and a novice barista.

Sarah Konstantino

DMBS ’16 Product Experience Manager – Fusion Agile Accelerator

Bio

Sarah is an experienced design-driven product and business strategist with a demonstrated history of working in health care technology and services. She is passionate about using empathy and industry-proven frameworks to solve big problems & drive meaningful innovation within the healthcare industry. She has helped new businesses cross the chasm of execution and launch in as little as 7 months.

She currently works as a Senior Product Experience Manager on the Fusion Team within Optum Technology, where she has spent the last 4 years working with teams to build and launch new products and services centered around those UnitedHealth Group is committed to serve, patients and providers.

Sarah is a graduate of the D’Amore-McKim School of Business, where she completed a dual concentration in Management & Marketing, in addition to a health science minor from Bouvé College of Health Sciences. During her time at Northeastern, Sarah was actively involved in Women in Business, The American Red Cross Club, Lead360 and volunteered as a fitness coach for FitNU. She completed 3 Co-ops during her 5-year tenure; including roles focused on healthcare delivery, improvement and consulting.

She loves gluten-free cooking and living an active lifestyle. In her free time, you can find her traveling across the globe exploring new cities and cultures.

Rebecca Love

MSN Nurse, Innovator, Speaker, Author, Connector

Bio

Rebecca Love, RN, BS, MSN, FIEL, is a nurse entrepreneur, inventor, author, TedX Speaker and first nurse featured on Ted.com, and part of the inaugural nursing panel featured at SXSW 2018.  Rebecca, was the first Director of Nurse Innovation & Entrepreneurship in the United States at Northeastern University School of Nursing – the founding initiative in the Country designed to empower nurses as innovators and entrepreneurs, where she founded the Nurse Hackathon, the movement has led to transformational change in the Nursing Profession. Rebecca is an experienced Nurse Entrepreneur, founding HireNurses.com in 2013 which was acquired in 2018, and currently serves as Vice President of Customer Strategy, OptimizeRx. In early 2019, Rebecca, along with a group of leading nurses in the world, founded and is President of SONSIEL: The Society of Nurse Scientists, Innovators, Entrepreneurs & Leaders, a non-profit that quickly attained recognition by the United Nations as an Affiliate Member to the UN. Rebecca is passionate about empowering nurses and creating communities to help nurses innovate, create and collaborate to start businesses and inventions to transform healthcare.

Rebecca holds a M.S. in Nursing from Northeastern University, B.A. in International Relations/Spanish from Boston University, and is currently Faculty at Norwich University, sits on the board of NextGen Ventures &  the Host Committee for the Massachusetts ACLU. She currently lives in Marblehead, Massachusetts with her husband and 3 children.

HSE placeholder icon

M. Nicole Marcey

MBA ’92 and Founder & Managing Counsel, Synesis Law P.C.

Bio

Nicole is the founder and Managing Counsel of Synesis Law P. C., a law firm providing counsel to mid-size companies.   Nicole has practiced at multinational law firms in Chicago, New York and Los Angeles providing legal counsel to Fortune 100 companies. Recognizing that integrating her legal knowledge with business strategy was both a strength and a passion, she went in-house at two multi-billion dollar conglomerates, obtained her MBA to round out her skill set and accepted a General Counsel position with a privately-held software development and implementation company.

Nicole is active in mentoring start-up health science companies. Her experience representing companies in the engineering, biomedical, technology and consumer products industries supports her skill in discerning business models and agreements that fit a company’s current needs and risks.

Rupal Patel

Founder & CEO, VocaliD
Professor, Northeastern University
Bio

Rupal is the Founder and CEO of VocaliD, a voice technology company that provides AI-generated voices with personality. VocaliD’s award-winning technology leverages the latest advances in machine learning, signal processing and voice analytics along with the company’s crowdsourced Voicebank to create inclusive, diverse and brand aligned voices for organizations and individuals with special needs. Rupal began her career as a speech clinician where she became fascinated with the potential of using speech technologies for assistive communication which then led to a doctorate in speech science. Her interdisciplinary research applies empirical evidence about speech motor control to develop novel communication technologies. She is currently on leave from Northeastern University where she is a tenured professor in the Bouve College of Health Sciences and Khoury College of Computer Science. Named one of The Top 11 Visionaries in Voice 2019 by Voicebot.ai and Fast Company’s 100 Most Creative People in Business, Rupal has been featured on TED, NPR, and in major international news and technology publications.

Carmen Sceppa

Dean of Bouvé College of Health Sciences at Northeastern University
Bio

Carmen Castañeda Sceppa, MD, PhD is the Dean of Bouvé College of Health Sciences and Professor at Northeastern University. She has taught at Northeastern since 2008 and served in a series of leadership roles culminating in her appointment as college dean in July 2018.

As a physician and nutrition scientist, Dr. Sceppa’s work centers around developing and testing lifestyle interventions to promote healthy aging. Her research examines health and wellness in settings that promote physical activity among underserved and vulnerable populations, specifically, older adults and the elderly, particularly Hispanics and African Americans.

Dr. Sceppa’s research provides evidence-based information to transform the way we think about healthy lifestyles. The Academy of Sciences and the Institute of Medicine have used her research findings to revise the Dietary Recommended Intake for protein in older adults. Her pioneering work on resistance exercise in older adults with kidney disease and diabetes was translated into clinical practice by the American Diabetes Association and adopted as standard of care. Her research also contributed to the American College of Sports Medicine’s and Heart Association’s recommendations for physical activity in older adults.

Continued funding for Dr. Sceppa’s translational program of research includes funding from the Brookdale Foundation, the International Life Sciences Institute, the National Institutes of Health (NIA, NINR, NIDDK, NHLBI), the National Space and Biomedical Research Institute (NSBRI), as well as corporations and foundations such as Novartis, Departments of Public Health, and Boston Children’s Hospital.

Dr. Sceppa has been an active and long-time member and contributor of the Gerontological Society of America (GSA) since 1994 and a GSA Fellow for Health Sciences Section since 2019. She has also been an active member of the American Society for Nutrition (ASN) since 1994, chair-elect from 2012-14 and chair of ASN’s Aging & Chronic Disease Research Interest Section from 2014-16.

Dr. Sceppa received her medical degree from Francisco Marroquín University in Guatemala City, Guatemala and her PhD in Nutrition from The Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University in Boston, Massachusetts. She is a native Spanish speaker and fluent in English.

Craig Sockol

MP ’79, PNT ’19
Life Science Entrepreneur

Bio

Craig Sockol is a life science entrepreneur who is currently the president and founder of Massbiolytics, an analytical reference testing laboratory for the Massachusetts Adult Use and Medical Cannabis product market. From 2006 to 2016 he was the president and founder of United Esoterics, a healthcare company providing decentralized esoteric laboratory services and diagnostic instrument-reagent systems to physicians’ practices across the country. Previously, Sockol was the founder and CEO of Repromedix Corp, the leading reproductive esoteric test laboratory offering innovative diagnostic solutions to the infertility market. He established a track record of 42% annual revenue growth, and raised over $7 million. Before joining Repromedix, Sockol was the co-founder and senior vice president of Immunotech Corp, where he was responsible for the development and worldwide marketing of novel immunodiagnostic laboratory products. In the course of building Immunotech, he developed over 35 FDA approved in-vitro diagnostic medical products resulting in a market leadership position in the United States for physician laboratory Thyroid test kits. He was the manager of new products and regulatory affairs at Baxter Healthcare-Clinical Assays and held technical positions at Ciba-Corning. Sockol holds an M.S. in clinical biochemistry from Northeastern University and a B.S. in chemistry from the University of Massachusetts. He was awarded the Rho Chi academic excellence membership for life sciences.

John Tremblay

E ’92, MBA ’98
Practice Lead, Health Context

Bio

John currently leads the Digital Health strategy, technology and lean innovation consultancy at Healthy Context, helping define and guide the strategy, definition and commercialization of mHealth applications, IoT wireless enablement of medical devices, patient home therapies, clinician dashboards and big data analytics. John has worked with companies such as Fresenius Medical Care, Medtronic, Bayer Consumer Health, NxStage Medical, Outset Medical, AllState and Verizon Wireless.

The balance of John’s 25+ years of experience includes founder, executive and product innovation roles within 7 startup ventures involving mobile, web, big data and digital media technologies, including Azuki Systems (acquired by Ericsson), Tatara Systems, Intraplex (acquired by Harris Corporation), Sycamore Networks and Microwave Radio (acquired by Adaptive Broadband).

John has both a technology innovation MBA and a BS in electrical engineering from Northeastern University where he conducted research in the area of radar signal processing. John is also an active angel investor with LaunchPad Venture Group and board member, mentor and instructor with various Northeastern entrepreneurship programs including the NSF I-Corps and Health Sciences Entrepreneurs.

Gene Tunik

Gene Tunik PhD PT

BS ’97, Associate Dean of Research and Innovation in the Bouvé College of Health Sciences at Northeastern University

Bio

Dr. Tunik received his B.S. in Physical Therapy from Northeastern University, PhD in Neuroscience from Rutgers University, and completed a postdoctoral fellowship at Department of Psychological and Brain Science at Dartmouth College. Prior to coming to Northeastern in 2015, Dr. Tunik has held faculty appointments at NYU and Rutgers University. His primary research interest is in the study of brain mechanisms involved in human motor control, motor learning, and motor recovery from disease.